These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 28593395)

  • 1. Anti-tumor Effects of Sorafenib Administered at Different Time Points in Combination with Transarterial Embolization in a Rabbit VX2 Liver Tumor Model.
    Tomozawa Y; Nitta N; Ohta S; Watanabe S; Sonoda A; Nitta-Seko A; Tsuchiya K; Murata K
    Cardiovasc Intervent Radiol; 2017 Nov; 40(11):1763-1768. PubMed ID: 28593395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transarterial Chemoembolization Using Sorafenib in a Rabbit VX2 Liver Tumor Model: Pharmacokinetics and Antitumor Effect.
    Kim GM; Kim MD; Kim do Y; Kim SH; Won JY; Park SI; Lee do Y; Shin W; Shin M
    J Vasc Interv Radiol; 2016 Jul; 27(7):1086-92. PubMed ID: 27179404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiofrequency ablation combined with transcatheter therapy in rabbit VX2 liver tumors: effects and histopathological characteristics.
    Duan X; Zhou G; Han X; Ren J; Zheng C; Liang H; Feng G
    Acta Radiol; 2015 Jan; 56(1):87-96. PubMed ID: 24425792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modified transarterial chemoembolization with locoregional administration of sorafenib for treating hepatocellular carcinoma: feasibility, efficacy, and safety in the VX-2 rabbit liver tumor model.
    Seidensticker M; Streit S; Nass N; Wybranski C; Jürgens J; Brauner J; Schulz N; Kalinski T; Seidensticker R; Garlipp B; Steffen I; Ricke J; Dudeck O
    Diagn Interv Radiol; 2016; 22(4):378-84. PubMed ID: 27328720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetic study of conventional sorafenib chemoembolization in a rabbit VX2 liver tumor model.
    Parvinian A; Casadaban LC; Hauck ZZ; van Breemen RB; Gaba RC
    Diagn Interv Radiol; 2015; 21(3):235-40. PubMed ID: 25835078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of VX2 as a Hepatocellular Carcinoma Model: Comparison of the Molecular Reaction of VX2 and HepG2 Tumor Cells to Sorafenib In Vitro.
    Nass N; Streit S; Wybranski C; Jürgens J; Brauner J; Schulz N; Powerski M; Ricke J; Kalinski T; Dudeck O; Seidensticker M
    Anticancer Res; 2017 Jan; 37(1):87-93. PubMed ID: 28011478
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A small interfering RNA targeting vascular endothelial growth factor efficiently inhibits growth of VX2 cells and VX2 tumor model of hepatocellular carcinoma in rabbit by transarterial embolization-mediated siRNA delivery.
    Zou Y; Guo CG; Yang ZG; Sun JH; Zhang MM; Fu CY
    Drug Des Devel Ther; 2016; 10():1243-55. PubMed ID: 27069355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatic arterial administration of sorafenib and iodized oil effectively attenuates tumor growth and intrahepatic metastasis in rabbit VX2 hepatocellular carcinoma model.
    Zhang L; Liu FY; Fu JX; Duan F; Fan QS; Wang MQ
    Int J Clin Exp Pathol; 2014; 7(11):7775-81. PubMed ID: 25550815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early treatment response to sorafenib for rabbit VX2 orthotic liver tumors: evaluation by quantitative contrast-enhanced ultrasound.
    Kong WT; Yuan HX; Cai H; Wang WP; Tang Y; Zhang XL
    Tumour Biol; 2015 Apr; 36(4):2593-9. PubMed ID: 25448880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antitumor effect of curcumin liposome after transcatheter arterial embolization in VX2 rabbits.
    Zhang X; Dai F; Chen J; Xie X; Xu H; Bai C; Qiao W; Shen W
    Cancer Biol Ther; 2019; 20(5):642-652. PubMed ID: 30621501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heat shock protein 70 expression and effect of combined transcatheter arterial embolization and radiofrequency ablation in the rabbit VX2 liver tumour model.
    Duan X; Zhou G; Zheng C; Liang H; Liang B; Song S; Feng G
    Clin Radiol; 2014 Feb; 69(2):186-93. PubMed ID: 24199849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of hypoxia-inducible factor-1alpha expression before and after transcatheter arterial embolization in rabbit VX2 liver tumors.
    Virmani S; Rhee TK; Ryu RK; Sato KT; Lewandowski RJ; Mulcahy MF; Kulik LM; Szolc-Kowalska B; Woloschak GE; Yang GY; Salem R; Larson AC; Omary RA
    J Vasc Interv Radiol; 2008 Oct; 19(10):1483-9. PubMed ID: 18922400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Poly(lactide-co-glycolide) microspheres for MRI-monitored delivery of sorafenib in a rabbit VX2 model.
    Chen J; White SB; Harris KR; Li W; Yap JW; Kim DH; Lewandowski RJ; Shea LD; Larson AC
    Biomaterials; 2015 Aug; 61():299-306. PubMed ID: 26022791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sorafenib increases efficacy of vorinostat against human hepatocellular carcinoma through transduction inhibition of vorinostat-induced ERK/NF-κB signaling.
    Hsu FT; Liu YC; Chiang IT; Liu RS; Wang HE; Lin WJ; Hwang JJ
    Int J Oncol; 2014 Jul; 45(1):177-88. PubMed ID: 24807012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro and in vivo evaluation of drug-eluting microspheres designed for transarterial chemoembolization therapy.
    Wang Y; Molin DG; Sevrin C; Grandfils C; van den Akker NM; Gagliardi M; Knetsch ML; Delhaas T; Koole LH
    Int J Pharm; 2016 Apr; 503(1-2):150-62. PubMed ID: 26965198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Feasibility and safety of sorafenib treatment in hepatocellular carcinoma patients with spontaneous rupture.
    Zheng SZ; Liu DJ; Sun P; Yu GS; Xu YT; Gong W; Liu J
    World J Gastroenterol; 2014 Nov; 20(43):16275-81. PubMed ID: 25473183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-tumour effects of transcatheter arterial embolisation administered in combination with thalidomide in a rabbit VX2 liver tumour model.
    Nitta-Seko A; Nitta N; Sonoda A; Otani H; Tsuchiya K; Ohta S; Takahashi M; Murata K
    Br J Radiol; 2011 Feb; 84(998):179-83. PubMed ID: 20959369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sorafenib and 2,3,5-triiodobenzoic acid-loaded imageable microspheres for transarterial embolization of a liver tumor.
    Choi JW; Park JH; Cho HR; Chung JW; Kim DD; Kim HC; Cho HJ
    Sci Rep; 2017 Apr; 7(1):554. PubMed ID: 28373713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metformin sensitizes sorafenib to inhibit postoperative recurrence and metastasis of hepatocellular carcinoma in orthotopic mouse models.
    You A; Cao M; Guo Z; Zuo B; Gao J; Zhou H; Li H; Cui Y; Fang F; Zhang W; Song T; Li Q; Zhu X; Yin H; Sun H; Zhang T
    J Hematol Oncol; 2016 Mar; 9():20. PubMed ID: 26957312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Texture analysis of intermediate-advanced hepatocellular carcinoma: prognosis and patients' selection of transcatheter arterial chemoembolization and sorafenib.
    Fu S; Chen S; Liang C; Liu Z; Zhu Y; Li Y; Lu L
    Oncotarget; 2017 Jun; 8(23):37855-37865. PubMed ID: 27911268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.